NCT07753369
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Henan Province Zhengzhou, Henan, China
- Jiangsu Provincial People's Hospital Nanjing, Jiangsu, China
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
Not yet recruiting
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
NCT07758673
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
Not yet recruiting
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
NCT07757412
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- AUH Aarhus, Denmark
- OUH Odense, Denmark
- North Estonia Medical Centre Tallinn, Estonia
- Tartu University Hospital Tartu, Estonia
Not yet recruiting
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
NCT07009899
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Not yet recruiting
FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT07221032
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT07754682
- Conditions
- Antibiotic Prophylaxis, B Cell Acute Lymphoblastic Leukemia (B-ALL), B Cell Lymphoma, +19 more
- Locations
-
Not specified
Not yet recruiting
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)
NCT07751471
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Not yet recruiting
Plasma ctDNA Monitoring in Pediatric Acute Leukemia
NCT07751588
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
- Locations
-
- Department of Pediatric Hematology/Oncology,Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Not yet recruiting
Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
NCT07518329
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
- Epworth HealthCare Richmond, Victoria, Australia
- St. Vincent's Hospital Sydney, New South Wales, Australia
Not yet recruiting
Digital Patient-Reported Assessment in Older Adults With Acute Leukemia
NCT07597590
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Hospital Universitario Central de Asturias (HUCA) Oviedo, Principality of Asturias, Spain